Author
Listed:
- Kentaro Kitano
(Harvard Medical School)
- Dana M. Schwartz
(Harvard Medical School)
- Haiyang Zhou
(Harvard Medical School
Second Military Medical University)
- Sarah E. Gilpin
(Harvard Medical School)
- Gregory R. Wojtkiewicz
(Richard B. Simches Research Center)
- Xi Ren
(Harvard Medical School)
- Cesar A. Sommer
(Boston University School of Medicine)
- Amalia V. Capilla
(Boston University School of Medicine)
- Douglas J. Mathisen
(Harvard Medical School)
- Allan M. Goldstein
(Harvard Medical School)
- Gustavo Mostoslavsky
(Boston University School of Medicine
Boston Medical Center)
- Harald C. Ott
(Harvard Medical School
Harvard Stem Cell Institute)
Abstract
Patients with short bowel syndrome lack sufficient functional intestine to sustain themselves with enteral intake alone. Transplantable vascularized bioengineered intestine could restore nutrient absorption. Here we report the engineering of humanized intestinal grafts by repopulating decellularized rat intestinal matrix with human induced pluripotent stem cell-derived intestinal epithelium and human endothelium. After 28 days of in vitro culture, hiPSC-derived progenitor cells differentiate into a monolayer of polarized intestinal epithelium. Human endothelial cells seeded via native vasculature restore perfusability. Ex vivo isolated perfusion testing confirms transfer of glucose and medium-chain fatty acids from lumen to venous effluent. Four weeks after transplantation to RNU rats, grafts show survival and maturation of regenerated epithelium. Systemic venous sampling and positron emission tomography confirm uptake of glucose and fatty acids in vivo. Bioengineering intestine on vascularized native scaffolds could bridge the gap between cell/tissue-scale regeneration and whole organ-scale technology needed to treat intestinal failure patients.
Suggested Citation
Kentaro Kitano & Dana M. Schwartz & Haiyang Zhou & Sarah E. Gilpin & Gregory R. Wojtkiewicz & Xi Ren & Cesar A. Sommer & Amalia V. Capilla & Douglas J. Mathisen & Allan M. Goldstein & Gustavo Mostosla, 2017.
"Bioengineering of functional human induced pluripotent stem cell-derived intestinal grafts,"
Nature Communications, Nature, vol. 8(1), pages 1-13, December.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-00779-y
DOI: 10.1038/s41467-017-00779-y
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-00779-y. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.